Healthcare provider profile · identity verified

Amy N Mandeville

Family Practice · WAUPACA, WI · NPI 1225478126

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	305	66
Pantoprazole Sodium	Pantoprazole Sodium	211	33
Levothyroxine Sodium	Levothyroxine Sodium	208	47
Gabapentin	Gabapentin	194	33
Lisinopril	Lisinopril	157	40
Eliquis	Apixaban	153	32
Omeprazole	Omeprazole	148	35
Trazodone Hcl	Trazodone Hcl	146	25
Amlodipine Besylate	Amlodipine Besylate	142	34
Tamsulosin Hcl	Tamsulosin Hcl	132	22
Furosemide	Furosemide	126	32
Allopurinol	Allopurinol	125	17
Sertraline Hcl	Sertraline Hcl	113	20
Metoprolol Succinate	Metoprolol Succinate	112	34
Simvastatin	Simvastatin	101	24
Metformin Hcl	Metformin Hcl	100	19
Jardiance	Empagliflozin	90	15
Hydrochlorothiazide	Hydrochlorothiazide	84	19
Losartan Potassium	Losartan Potassium	80	23
Metoprolol Tartrate	Metoprolol Tartrate	79	16
Rosuvastatin Calcium	Rosuvastatin Calcium	79	22
Finasteride	Finasteride	76	11
Buspirone Hcl	Buspirone Hcl	70	suppressed
Potassium Chloride	Potassium Chloride	66	22
Spironolactone	Spironolactone	63	14
Metformin Hcl Er	Metformin Hcl	62	14
Carvedilol	Carvedilol	59	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	11
Citalopram Hbr	Citalopram Hydrobromide	57	suppressed
Fluticasone Propionate	Fluticasone Propionate	51	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	25
Clopidogrel	Clopidogrel Bisulfate	45	12
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	11
Latanoprost	Latanoprost	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	11
Bumetanide	Bumetanide	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Constulose	Lactulose	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Famotidine	Famotidine	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Ozempic	Semaglutide	24	suppressed
Paliperidone Er	Paliperidone	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Prednisone	Prednisone	23	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Baclofen	Baclofen	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Lurasidone Hcl	Lurasidone Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fosinopril Sodium	Fosinopril Sodium	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	17	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Xtampza Er	Oxycodone Myristate	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Cefdinir	Cefdinir	13	13
Cimetidine	Cimetidine	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Atenolol	Atenolol	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Depakote	Divalproex Sodium	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glipizide	Glipizide	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error